ipacm

Archives of Clinical Microbiology

ISSN - 1989-8436

Research Article - (2017) Volume 8, Issue 3

View PDF Download PDF

The Effects of Berberine on Clostridium Perfringens Induced Necrotic Enteritis in Broiler Chickens

 

Author info »

Abstract

Background: Necrotic Enteritis, caused by C. perfringens is a major bacterial disease in chickens that results in substantial economic losses to the poultry industry. Drug resistance and increased pressure to reduce the use of antimicrobial growth promoters has stimulated the need to search for alternatives. This two-part study investigated the use of the natural herbal compound Berberine in broiler chickens for the control of Necrotic Enteritis.

Methods and findings: Phase 1 evaluated Berberine in-water at 0.1 g/L and 1.0 g/L in vivo against C. perfringens induced disease in broiler chickens. Results demonstrated efficacy towards the disease based on significantly decreased mortality and lesion scores at 1.0 ml/L Berberine treatment. Despite this, bodyweight, and feed and water consumption were greatly decreased in treated groups. Bursa of fabricus to bodyweight ratio results indicate there was no distinct damage to the immune system, suggesting palatability of Berberine in-water may have been the principal cause. The follow-up Phase 2 trial investigated the in vivo palatability of Berberine in-feed at 2.0 g/kg in non-challenged broiler chickens. Bodyweight, feed consumption and feed conversion ratio were found to not be affected compared to controls. However, water consumption was significantly increased in treated groups.

Conclusions: Therefore from the present study, it can be concluded that Berberine has the potential to contribute to the control of Necrotic Enteritis, and that Berberine in-feed treatment alleviates the bird productivity concerns present when Berberine is administered via water.

References

  1. Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytotherapy research 22:  999-1012.
  2. Xu JL, Wang,Xu B (2004) Research development of Coptischinensis. Zhongguoyixuekexueyuanxuebao.ActaAcademiaeMedicinaeSinicae 26: 704-707.
  3. Cordell  GA, Quinn‐Beattie ML, Farnsworth NR (2001) The potential of alkaloids in drug discovery. Phytotherapy Research15: 183-205.
  4. Tillhon M (2012) Berberine: new perspectives for old remedies. Biochemical pharmacology 84: 1260-1267.
  5. Castanon J (2007) History of the use of antibiotic as growth promoters in European poultry feeds. Poultry science86: 2466-2471.
  6. Dibner J (2005) J. Richards, Antibiotic growth promoters in agriculture: history and mode of action. Poultry science 84:634-643.
  7. No ER (2003) European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition. Off. J. Eur. Union 21: 1831.
  8. Van der Sluis W (2000)Clostridial enteritis is an often underestimated problem. World Poultry 16: 42-43.
  9. Van der Sluis W (2000)Clostridial enteritis-a syndrome emerging world wide. World Poultry 16: 56-57.
  10. Dahiya J (2006) Potential strategies for controlling necrotic enteritis in broiler chickens in post-antibiotic era. Animal Feed Science and Technology129:60-88.
  11. SongerJG, Meer RR (1996) Genotyping ofClostridiumperfringensby Polymerase Chain Reaction is a Useful Adjunct to Diagnosis of Clostridial Enteric Disease in Animals. Anaerobe2: 197-203.
  12. Williams R (2005)Intercurrentcoccidiosis and necrotic enteritis of chickens: rational, integrated disease management by maintenance of gut integrity. Avian Pathology 34:159-180.
  13. Elwinger KA (1991) Factors affecting the incidence of necrotic enteritis caecal carriage of Clostridium perfringens and bird performance in broiler chicks. ActaVeterinariaScandinavica 33:369-378.
  14. Kaldhusdal M (2001) Reduced incidence of Clostridium perfringens-associated lesions and improved performance in broiler chickens treated with normal intestinal bacteria from adult fowl. Avian diseases 2: 149-156.
  15. Gholamiandehkordi AR (2007) Quantification of gut lesions in a subclinical necrotic enteritis model. Avian Pathology 36:375-382.
  16. Stanley D (2014) Differential responses of cecalmicrobiota to fishmeal, Eimeria and Clostridium perfringens in a necrotic enteritis challenge model in chickens. PLoS One 9:  e104739.
  17. Malik TA (2014) In vivo anticoccidial activity of berberine [18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium]–an isoquinoline alkaloid present in the root bark of Berberislycium. Phytomedicine21:663-669.
  18. Malik TA (2016) Synergistic approach for treatment of chicken coccidiosis using berberine–A plant natural product. Microbial pathogenesis93: 56-62.
  19. Bartlett JG (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New England Journal of Medicine 298: 531-534.
  20. Hatheway CL (1990)Toxigenic clostridia. Clinical microbiology reviews 3: 66-98.
  21. Wu SB (2014) Two necrotic enteritis predisposing factors, dietary fishmeal and Eimeria infection, induce large changes in the caecalmicrobiota of broiler chickens. Veterinary microbiology169:188-197.
  22. Lanckriet A (2010)The effect of commonly used anticoccidials and antibiotics in a subclinical necrotic enteritis model. Avian Pathology 39:  63-68.
  23. Wu S, Rodgers N,Choct M (2010) Optimized necrotic enteritis model producing clinical and subclinical infection of Clostridium perfringens in broiler chickens. Avian diseases 54: 1058-1065.
  24. McReynolds J (2004) Evaluation of immunosuppressants and dietary mechanisms in an experimental disease model for necrotic enteritis. Poultry science 83:1948-1952.
  25. Prescott J (1979)The prevention of experimentally induced necrotic enteritis in chickens by avoparcin. Avian diseases 5: 1072-1074.
  26. Kalavathy R (2003) Effects of Lactobacillus cultures on growth performance, abdominal fat deposition, serum lipids and weight of organs of broiler chickens. British Poultry Science 44: 139-144.
  27. Rathgeber B (2008) Growth performance and spleen and bursa weight of broilers fed yeast beta-glucan. Canadian journal of animal science 88: 469-473.
  28. Immerseel FV (2004) Clostridium perfringens in poultry: an emerging threat for animal and public health. Avian Pathology 33: 537-549.
  29. Teuber M (2001) Veterinary use and antibiotic resistance. Current opinion in microbiology4: 493-499.
  30. Shen Y (2010)The effects of berberine on the magnitude of the acute inflammatory response induced by Escherichia coli lipopolysaccharide in broiler chickens. Poultry science89:13-19.
  31. Akhter M,Sabir M, Bhide N (1977) Anti-inflammatory effect of berberine in rats injected locally with cholera toxin. The Indian journal of medical research 65: 133-141.
  32. Rabbani G (1987)Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. Journal of infectious diseases155: 979-984.
  33. Sack RB, Froehlich JL (1982)Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infection and immunity35: 471-475.
  34. Ahn YJ (2000)Cordycepin: Selective Growth Inhibitor Derived from Liquid Culture of Cordyceps m ilitaris against Clostridium spp. Journal of agricultural and food chemistry48: p. 2744-2748.
  35. BhadraKM,Maiti GSK (2008) Berberine–DNA complexation: New insights into the cooperative binding and energetic aspects. BiochimicaetBiophysicaActa (BBA)-General Subjects 1780: 1054-1061.
  36. Chae SH (1999) Growth-inhibiting effects of Coptis japonica root-derived isoquinoline alkaloids on human intestinal bacteria. Journal of agricultural and food chemistry 47: 934-938.
  37. Lim MY (2007) Antimicrobial activity of 5-hydroxy-1, 4-naphthoquinone isolated from Caesalpiniasappan toward intestinal bacteria. Food Chemistry100: 1254-1258.
  38. Delzenne NM (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews Endocrinology 7:639-646.
  39. Lv Z(2015)Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. Antimicrobial agents and chemotherapy59:3726-3735.
  40. Zhang X (2012) Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PloS one7: e42529.
  41. CaniPD (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091-1103.
  42. PengL (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. The Journal of nutrition 139: 1619-1625.
  43. Jeong HW (2009)Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology-Endocrinology and Metabolism296: E955-E964.
  44. Zhang Q (2011) Preventive effect of Coptischinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food and Chemical Toxicology 49: 61-69.
  45. Al-Sheikhly F, Al-Saieg A (1980) Role of coccidia in the occurrence of necrotic enteritis of chickens. Avian diseases 8: 324-333.
  46. Yuan JX, Shen X, Zhu J (1994) Effect of berberine on transit time of human small intestine. ZhongguoZhong xi yijie he zazhiZhongguoZhongxiyijiehezazhi= Chinese journal of integrated traditional and Western medicine/ZhongguoZhong xi yijie he xuehui, ZhongguoZhongyiyanjiuyuanzhu ban 14):  718-720.
  47. Wang Y (2013) Sensory evaluation of the taste of berberine hydrochloride using an Electronic Tongue. Fitoterapia86: 137-143.
  48. Jahnke GD (2006) Developmental toxicity evaluation of berberine in rats and mice. Birth Defects Research Part B: Developmental and Reproductive Toxicology 77:195-206.
  49. Program NT (2010) Toxicology and carcinogenesis studies of goldenseal root powder (Hydrastis Canadensis) in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program technical report series1: 562.
  50. Zhang H (2013)The effects of Forsythia suspensa extract and berberine on growth performance, immunity, antioxidant activities, and intestinal microbiota in broilers under high stocking density. Poultry science92:1981-1988.
  51. Schat KA, Skinner MA (2008)Avian immunosuppressive diseases and immune evasion. Avian immunology 6: 299.
  52. Cazaban C (2015) Proposed bursa of fabricius weight to body weight ratio standard in commercial broilers. Poultry Science94: 2088-2093.
  53. Xia X (2011)Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS one 6: e16556.
  54. Yin J (2013) Metformin and berberine promote glucose metabolism via inhibiting mitochondrial respiratory chain complex I independently of AMPK activation in DIABETOLOGIA. SPRINGER 233 SPRING ST, NEWYORK, NY 10013 USA 22: 1256.
  55. Zhang Q (2014)Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine. BMC complementary and alternative medicine14:188.

Author Info

 

, DOI: 10.4172/1989-8436.100044

Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

iomcworld scan

Journal Highlights

Journal Flyer

Flyer